Estrogen Cream Near the Urethra: Four TAPER Trial Checks

Before changing where you apply a prescribed cream, check the comparison’s doses, outcome and definition of success.

The comparison changed both location and amount

TAPER randomized 114 postmenopausal participants, averaging 71 years; 92% were White.¹

The registry specifies 0.01% estradiol cream: 0.5 g around the urethra using a finger, versus 1 g inside the vagina using an applicator. Both groups used it nightly for 14 days, then twice weekly.²

These are study regimens to discuss with a prescriber. Bring your tube or a photograph of its label so the conversation identifies the product you actually have.

“Noninferior” came with a wide allowance

At six months, 29/57 periurethral participants and 30/57 intravaginal participants were UTI-free. The difference was −1.75 percentage points; its 95% confidence interval spanned −20 to +17 points. Its noninferiority margin was 25 points.¹

The interval still allowed 20 fewer UTI-free people per 100 with periurethral use. Identical protection was not established.¹

A useful question is: “How much uncertainty about infection prevention would you consider acceptable before changing my application method?”

The trial does not answer every reason for switching

Unblinded, TAPER had no placebo group.¹

It excluded people unable to use an applicator without caregiver assistance.²

If insertion hurts or your hands make an applicator difficult to manage, explain that specific problem. Ask whether a demonstration, assistance or a different prescribed preparation would address it. Do not assume the study’s eligibility criteria match your situation.

The prevention plan still needs a review date

NICE’s³ guidance for England considers vaginal estrogen for recurrent UTI when behavioral and hygiene measures are ineffective or unsuitable. It includes the person’s preferred preparation in the decision, calls for review within 12 months or sooner by agreement, and advises against systemic HRT specifically for preventing recurrent UTIs.³

For the appointment, write down your current application instructions, any missed applications and what makes them difficult. Ask the prescriber to put any revised amount, site and schedule in writing, along with when to reassess the plan.

Bring the bladder history too

“The Change” in Laugh, Sneeze, Jump brings urinary and vaginal symptoms into the same menopause discussion. It suggests recording burning, infections and hormone-treatment changes with dates. That page can accompany your cream instructions, so the clinician can review symptoms alongside how you use it.

Our vaginal estrogen and recurrent UTI guide covers the broader prevention evidence.